Skip to main content
. 2022 Jun 28;13:857443. doi: 10.3389/fimmu.2022.857443

Figure 1.

Figure 1

Flowchart of the study. *Reviews and articles describing patients with a single disease were excluded. **Articles describing patients without key information or aquaporin-4-antibody-negative NMOSD were excluded. There were 15, 18, and 46 NMDARe patients overlapped with MS, AQP4-Ab-positive NMOSD, and MOGAD, respectively.